◆ Market Data --:--
Commodities
Loading...
📈 Yields & Rates
Loading...
💱 FX Rates
Loading...
📈 Market Pulse
Loading...
🏛 Congress Trades
Loading...
👤 Insider Trades
Loading...

Scandium Canada Ltd.

Financial Statements (IFRS) · Amounts in CAD
5 10 All
Income Statement
Balance Sheet
Cash Flow
Line Item Q4 2025Nov 30, 2025 Q3 2025Aug 31, 2025 Q2 2025May 31, 2025 Q1 2025Feb 28, 2025 Q4 2024Nov 30, 2024
Total Revenue 0.00 0.00 0.00 23,010 0.00
Operating Revenue 0.00 0.00 0.00 23,010 0.00
Cost Of Revenue 169.00 0.00 0.00 18,116 169.00
Gross Profit -169.00 0.00 0.00 4,894 -169.00
Selling General And Administration 439,218 258,582 283,258 256,807 372,254
General And Administrative Expense 439,218 258,582 283,258 256,807 372,254
Research And Development 18,382 -9,109 63,594 161,019 180,348
Depreciation And Amortization In Income Statement -- 169.00 169.00 170.00 --
Other Operating Expenses 122,960 19,102 -34,456 -35,677 93,017
Operating Expense 581,083 271,629 317,486 401,248 646,587
Operating Income -581,252 -271,629 -317,486 -396,354 -646,756
EBIT -256,408 -263,678 -313,371 -396,354 -648,295
Interest Expense 10,222 -84,320 124,619 -- 0.00
Interest Expense Non Operating 10,222 -84,320 124,619 -- 0.00
Interest Income 1,853 7,951 4,115 3,769 1,705
Interest Income Non Operating 1,853 7,951 4,115 3,769 1,705
Net Interest Income -8,369 92,271 -120,504 3,769 1,705
Other Income Expense 322,991 -- -- -- -3,244
Other Non Operating Income Expenses -3,244 -- -- -- -3,244
Special Income Charges 326,235 -- -- -- 0.00
Pretax Income -266,630 -179,358 -437,990 -392,585 -648,295
Tax Provision -- -199,546 0.00 0.00 0.00
Tax Effect Of Unusual Items 0.00 0.00 0.00 0.00 0.00
Net Income From Continuing And Discontinued Operation -266,630 20,188 -437,990 -392,585 -648,295
Net Income From Continuing Operation Net Minority Interest -266,630 20,188 -437,990 -392,585 -648,295
Net Income Including Noncontrolling Interests -266,630 20,188 -437,990 -392,585 -648,295
Net Income Common Stockholders -266,630 20,188 -437,990 -392,585 -648,295
Net Income -266,630 20,188 -437,990 -392,585 -648,295
EBITDA -255,395 -263,509 -312,360 -395,343 -647,284
Normalized EBITDA -581,630 -263,509 -312,360 -395,343 -647,284
Reconciled Depreciation 1,013 -2,356 1,011 1,011 1,011
Basic EPS -0.00 -- -0.00 -0.00 -0.00
Diluted EPS -0.00 -- -0.00 -0.00 -0.00
Basic Average Shares 357.2M -- 300.7M 292.9M 280.4M
Diluted Average Shares 389.3M -- 300.7M 292.9M 280.4M
Total Unusual Items 326,235 -- -- -- 0.00
Total Unusual Items Excluding Goodwill 326,235 -- -- -- 0.00
Tax Rate For Calcs 0.00 0.15 0.00 0.00 0.00
Normalized Income -592,865 20,188 -437,990 -392,585 -648,295
Depreciation Amortization Depletion Income Statement -- 169.00 169.00 170.00 --
Depreciation Income Statement -- 169.00 169.00 170.00 --
Diluted NI Availto Com Stockholders -266,630 20,188 -437,990 -392,585 -648,295
Gain On Sale Of Ppe 326,235 -- -- -- 0.00
Net Income Continuous Operations -266,630 20,188 -437,990 -392,585 -648,295
Net Non Operating Interest Income Expense -8,369 92,271 -120,504 3,769 1,705
Other Gand A 187,773 130,240 112,981 76,561 178,784
Other Taxes 523.00 2,885 4,921 18,929 968.00
Reconciled Cost Of Revenue 169.00 2,525 0.00 17,275 169.00
Salaries And Wages 251,445 128,342 170,277 180,246 193,470
Total Expenses 581,252 271,629 317,486 419,364 646,756
Line Item Q4 2025Nov 30, 2025 Q3 2025Aug 31, 2025 Q2 2025May 31, 2025 Q1 2025Feb 28, 2025 Q4 2024Nov 30, 2024
Cash And Cash Equivalents 915,894 397,364 756,560 664,522 166,444
Cash Cash Equivalents And Short Term Investments 915,894 397,364 756,560 664,522 166,444
Cash Financial 915,894 397,364 756,560 664,522 166,444
Receivables 80,319 369,053 760,025 726,366 216,177
Prepaid Assets 90,630 64,057 34,377 37,815 108,158
Current Assets 1.1M 830,474 1.6M 1.4M 490,779
Net PPE 14.5M 14.3M 14.0M 13.9M 14.5M
Total Non Current Assets 14.5M 14.3M 14.0M 13.9M 14.5M
Total Assets 15.6M 15.1M 15.6M 15.4M 15.0M
Current Debt 399,851 389,629 416,515 -- --
Current Debt And Capital Lease Obligation 399,851 389,629 416,515 -- --
Payables And Accrued Expenses 1.5M 1.7M 2.2M 2.2M 2.1M
Current Deferred Revenue 54,562 73,449 92,500 6,163 76,163
Other Current Liabilities 112,365 112,365 311,911 311,911 --
Current Liabilities 2.1M 2.2M 3.0M 2.5M 2.2M
Total Non Current Liabilities Net Minority Interest 0.00 0.00 0.00 0.00 0.00
Total Liabilities Net Minority Interest 2.1M 2.2M 3.0M 2.5M 2.2M
Common Stock 18.5M 17.9M 17.8M 17.7M 17.4M
Capital Stock 18.5M 17.9M 17.8M 17.7M 17.4M
Additional Paid In Capital 4.4M 4.3M 4.2M 4.2M 4.1M
Retained Earnings -11.2M -10.9M -10.9M -10.5M -10.1M
Common Stock Equity 13.5M 12.9M 12.6M 12.9M 12.9M
Stockholders Equity 13.5M 12.9M 12.6M 12.9M 12.9M
Total Equity Gross Minority Interest 13.5M 12.9M 12.6M 12.9M 12.9M
Total Capitalization 13.5M 12.9M 12.6M 12.9M 12.9M
Net Tangible Assets 13.5M 12.9M 12.6M 12.9M 12.9M
Tangible Book Value 13.5M 12.9M 12.6M 12.9M 12.9M
Working Capital -1.0M -1.4M -1.4M -1.0M -1.7M
Invested Capital 13.9M 13.3M 13.0M 12.9M 12.9M
Total Debt 399,851 389,629 416,515 -- --
Share Issued 362.2M 334.8M 318.1M 312.6M 282.5M
Ordinary Shares Number 362.2M 334.8M 318.1M 312.6M 282.5M
Current Deferred Liabilities 54,562 73,449 92,500 6,163 76,163
Other Equity Interest 1.8M 1.6M 1.5M 1.5M 1.5M
Other Receivables -- 307,561 53,959 9,975 57,291
Taxes Receivable 80,319 61,492 706,066 716,391 158,886
Line Item Q4 2025Nov 30, 2025 Q3 2025Aug 31, 2025 Q2 2025May 31, 2025 Q1 2025Feb 28, 2025 Q4 2024Nov 30, 2024
Operating Cash Flow -625,143 -81,054 -192,430 -259,589 -312,415
Cash Flow From Continuing Operating Activities -625,143 -81,053 -192,430 -259,589 -312,415
Depreciation And Amortization 1,013 -2,356 1,011 1,011 1,011
Depreciation Amortization Depletion 1,013 -2,356 1,011 1,011 1,011
Stock Based Compensation 134,067 10,406 46,372 51,478 76,092
Deferred Tax 10,222 -199,546 0.00 0.00 0.00
Deferred Income Tax 10,222 -199,546 0.00 0.00 0.00
Change In Working Capital -177,580 49,956 198,177 80,507 258,777
Change In Receivables -18,827 24,276 97,704 32,705 304,950
Change In Payables And Accrued Expense -113,293 147,860 10,698 47,459 -130,587
Change In Other Working Capital -18,887 -92,500 86,337 -70,000 -5,260
Other Non Cash Items -- 40,298 -- -- --
Capital Expenditure -329,866 -625,933 -249,172 -58,303 -7,341
Purchase Of PPE -329,866 -625,933 -249,172 -58,303 -7,341
Net PPE Purchase And Sale 60,134 -625,933 -249,172 -58,303 -7,341
Investing Cash Flow 367,695 -429,756 -141,172 73,060 -7,341
Cash Flow From Continuing Investing Activities 367,695 -429,756 -141,172 73,060 -7,341
Issuance Of Debt -- -- 410,000 -- --
Net Issuance Payments Of Debt -- -- 410,000 -- --
Issuance Of Capital Stock 564,500 334,000 0.00 739,500 419,500
Net Common Stock Issuance 564,500 334,000 0.00 739,500 419,500
Financing Cash Flow 775,978 151,614 425,640 684,607 384,244
Cash Flow From Continuing Financing Activities 775,978 151,614 425,640 684,607 384,244
Changes In Cash 518,530 -359,196 92,038 498,078 64,488
Beginning Cash Position 397,364 756,560 664,522 166,444 101,956
End Cash Position 915,894 397,364 756,560 664,522 166,444
Free Cash Flow -955,009 -706,987 -441,602 -317,892 -319,756
Amortization Cash Flow -- -- -- 1,011 --
Amortization Of Intangibles -- -- -- 1,011 --
Change In Prepaid Assets -26,573 -29,680 3,438 70,343 89,674
Common Stock Issuance 564,500 334,000 0.00 739,500 419,500
Depreciation 1,013 -2,356 1,011 -- 1,011
Long Term Debt Issuance -- -- 410,000 -- --
Net Income From Continuing Operations -592,865 20,188 -437,990 -392,585 -648,295
Net Long Term Debt Issuance -- -- 410,000 -- --
Net Other Financing Charges -30,041 -- -- -54,893 -35,256
Net Other Investing Changes 307,561 196,177 108,000 131,363 --
Proceeds From Stock Option Exercised 241,519 -- 15,640 -- 0.00
Sale Of PPE 390,000 -- -- -- 0.00
NEWS
Loading news...
TRENDING
Loading...